Shopping Cart
- Remove All
- Your shopping cart is currently empty
Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody with anticancer activity that inhibits the growth of cancer cells.Enoticumab binds human Dll4 and disrupts Notch-mediated signaling.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $263 | In Stock | |
5 mg | $795 | In Stock | |
10 mg | $1,260 | In Stock | |
25 mg | $1,870 | In Stock | |
50 mg | $2,520 | In Stock |
Description | Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody with anticancer activity that inhibits the growth of cancer cells.Enoticumab binds human Dll4 and disrupts Notch-mediated signaling. |
In vivo | In an ovarian xenograft model, Enoticumab demonstrates specific in vivo activity. EGN421 (2.5 mg/kg, administered once weekly) achieved tumor growth inhibition of 86% and 83% in subcutaneous TOV-112D and intraperitoneal A2780 human tumor xenograft models in mice, respectively. [1] |
Alias | SAR-153192, SAR153192, REGN-421, REGN421 |
Cas No. | 1192578-27-0 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.